A Statement of the <scp>MDS</scp> on Biological Definition, Staging, and Classification of Parkinson's Disease
Francisco Cardoso(Hospital de Santa Marta), Claudia Trenkwalder(Universitätsmedizin Göttingen), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Victor S.C. Fung(The University of Sydney), Cristina Sampaio(Dorothea Haus Ross Foundation), Irene Litvan(University of California, San Diego), David J. Burn(Ollscoil na Gaillimhe – University of Galway), Christopher G. Goetz(Rush University Medical Center), Charles H. Adler(WinnMed), Marina A.J. Tijssen(University Medical Center Groningen), Christine Klein(University of Lübeck), Ronald B. Postuma(Montreal Neurological Institute and Hospital), Bastiaan R. Bloem(Radboud University Nijmegen), Per Svenningsson(Karolinska Institutet), Shen‐Yang Lim(Monash University Malaysia), Michael S. Okun(University of Florida), Louis C.S. Tan(National Neuroscience Institute), Tiago Mestre(University of Ottawa), Thomas Gasser(Hertie Institute for Clinical Brain Research), Sarah Wahlstrom‐Helgren(International Parkinson and Movement Disorder Society), Njideka Okubadejo(University of Lagos), Brit Mollenhauer(Paracelsus Elena Klinik Kassel), Oscar S. Gershanik(Instituto de Neurología Cognitiva), Wassilios G. Meissner(Centre National de la Recherche Scientifique), Taiji Tsunemi(Juntendo University), Michael S. Fitts(University of Alabama at Birmingham), Anthony E. Lang(University of Toronto)
Cited by 83
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k